• Pharma
  • May 20, 2025
  • 423 views
Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…